Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134973) titled 'Case reports: two cases of ischemic bowel disease caused by oxaliplatin' on Oct. 22.
Study Type: Observational study
Study Design:
Case study
Primary Sponsor: Wuxi people's Hospital
Condition:
Oxaliplatin is a first-line platinum-based chemotherapy drug widely used for treating digestive tract malignancies such as colorectal cancer and gastric cancer. Its common adverse reactions include neurotoxicity, bone marrow suppression, and gastrointestinal reactions. Ischemic colitis (IC), as a rare but severe vascular toxicity reaction, presents mainly with abdominal pain, diarrhea, hematochezi
Recruitment Status: N...